I-Gel Versus Disposable Laryngeal Mask (LMA) for General Anesthesia (GA) With Controlled Ventilation

NCT ID: NCT00668278

Last Updated: 2009-01-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-02-29

Study Completion Date

2009-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized controlled trial comparing performance of the I-gel and disposable Laryngeal Mask Airways under controlled ventilation. 200 patients, 100 in each arm. Measurement of peak airway and sealing pressures. Postoperative questionnaires at 1 and 24hrs.

Hypothesis

There is no difference between the performance\* of the I-gel and disposable laryngeal mask airways for controlled ventilation under general anesthesia.

\*as defined by peak airway pressure and sealing pressures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Laryngeal Mask Airway insertion

Group Type ACTIVE_COMPARATOR

Insertion of laryngeal mask airway (AuraOnce mask)

Intervention Type DEVICE

Insertion of laryngeal mask airway under anaesthesia: Fentanyl 1-2mcg/kg; Propofol 1-3mg/kg; Atracurium 0.5mg/kg; AuraOnce disposable laryngeal mask

Measurement of airway pressures

Intervention Type OTHER

Measurement of peak airway pressure under steady state; measurement of device seal pressure

B

I-gel insertion

Group Type ACTIVE_COMPARATOR

Insertion of I-gel airway

Intervention Type DEVICE

Insertion of I-gel airway under anaesthesia; Fentanyl 1-2mcg/kg; Propofol 1-3mg/kg; Atracurium 0.5mg/kg

Measurement of airway pressures

Intervention Type OTHER

Measurement of peak airway pressure under steady state; measurement of device seal pressure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Insertion of laryngeal mask airway (AuraOnce mask)

Insertion of laryngeal mask airway under anaesthesia: Fentanyl 1-2mcg/kg; Propofol 1-3mg/kg; Atracurium 0.5mg/kg; AuraOnce disposable laryngeal mask

Intervention Type DEVICE

Insertion of I-gel airway

Insertion of I-gel airway under anaesthesia; Fentanyl 1-2mcg/kg; Propofol 1-3mg/kg; Atracurium 0.5mg/kg

Intervention Type DEVICE

Measurement of airway pressures

Measurement of peak airway pressure under steady state; measurement of device seal pressure

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and females.
* Age 18-89 inclusive.
* ASA grade 1-2.
* Elective surgery

Exclusion Criteria

* Emergency surgery.
* Surgery within the peritoneum.
* Surgery requiring prone or steep head-down positioning.
* Patients at increased risk of aspiration
Minimum Eligible Age

18 Years

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Antrim Area Hospital

OTHER

Sponsor Role collaborator

Northern Health and Social Care Trust

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Antrim Area Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

William J Donaldson, MBBS FRCA

Role: PRINCIPAL_INVESTIGATOR

Antrim Area Hospital, Northern Health and Social Care Trust, National Health Service, United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07/NIR01/124

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.